The State and Consequences of Dermatology Drug Prices in the United States.

Authors

Joerg Albrecht
Mark Lebwohl
Maryam M Asgari
Daniel D Bennett
Ashley Cook
Colby C Evans
Lawrence J Green, George Washington UniversityFollow
Julie A Hodge
Arianne S Kourosh
Mary E Maloney
Leah M Howard
Elise A Olsen
Steven P Rosenberg
Adam Rubin
Dow B Stough
Susan C Taylor
Bruce Alan Brod

Document Type

Journal Article

Publication Date

9-1-2016

Journal

Journal of the American Academy of Dermatology

Volume

75

Issue

3

DOI

10.1016/j.jaad.2016.03.053

Keywords

Dermatologic Agents; Drug Costs; Drugs, Generic; Health Expenditures; Humans; Insurance, Pharmaceutical Services; Medicaid; Medicare; Needs Assessment; Pharmaceutical Services; United States; United States Food and Drug Administration

APA Citation

Albrecht, J., Lebwohl, M., Asgari, M., Bennett, D., Cook, A., Evans, C., Green, L., Hodge, J., Kourosh, A., Maloney, M., Howard, L., Olsen, E., Rosenberg, S., Rubin, A., Stough, D., Taylor, S., & Brod, B. (2016). The State and Consequences of Dermatology Drug Prices in the United States.. Journal of the American Academy of Dermatology, 75 (3). http://dx.doi.org/10.1016/j.jaad.2016.03.053

Peer Reviewed

1